Valued at USD 2.5 billion in 2024, the apheresis equipment market is projected to reach USD 2.68 billion in 2025 and USD 5 billion by 2034, growing at a CAGR of 7.00% during the forecast period 2025–2034. Growth is driven by expanding applications in therapeutic plasma exchange and blood component separation, supported by advances in medical technology, a rising prevalence of chronic diseases and growing demand for blood components worldwide.

Core Technology in the Apheresis Equipment Market

Apheresis equipment draws blood, typically from a vein, and passes it through a machine that uses centrifugal or membrane-based techniques to isolate elements such as plasma, platelets, white blood cells or red blood cells. The targeted component is collected separately while the remaining blood is returned to the donor or patient. Blood component separation underpins both donor collection and therapeutic procedures, making the technology central to modern transfusion and treatment workflows. The technology is a specialized medical device, increasingly shaped by automated and portable designs that enhance efficiency and safety.

Browse Insights:

https://www.polarismarketresearch.com/industry-analysis/global-apheresis-equipment-market

Therapeutic Plasma Exchange and Chronic Disease Demand

Therapeutic plasma exchange and cytapheresis are used to treat autoimmune diseases, blood disorders and certain cancers. Patients with Guillain-Barre syndrome or myasthenia gravis benefit from plasma exchange that removes harmful antibodies from the bloodstream. As the incidence of these conditions rises, and as an aging population proves more susceptible to chronic illness, demand for procedures and equipment increases. Expanding healthcare infrastructure in emerging economies and greater awareness of blood donation further support adoption. Advances in medical technology and rising demand for blood components are additional growth catalysts.

Disposable Apheresis Kits Dominate Product Revenue

By product, the market is segmented into disposable apheresis kits and devices, and the kits segment dominated in 2024. These single-use kits, which include tubing, filters and collection bags, ensure sterility and safety, reduce the risk of cross-contamination and streamline procedures for providers. A growing emphasis on infection control and patient safety, together with a rising number of apheresis procedures, continues to raise demand for high-quality disposable apheresis kits as recurring consumables. Their convenience and ease of use also make the apheresis process more efficient for healthcare providers.

Hematology and Leukapheresis Applications

By application, hematology held the dominant revenue share in 2024 owing to high demand for apheresis in managing blood-related disorders. Conditions such as leukemia, multiple myeloma, lymphoma and sickle cell anemia require regular therapeutic apheresis. Leukapheresis is essential for patients with high white blood cell counts, while erythrocytapheresis is critical for sickle cell disease. Renal diseases and neurology complete the application segmentation, and growing adoption of apheresis as a frontline treatment has significantly driven equipment demand in hematology. Multiple myeloma and lymphoma are also cited among hematologic conditions requiring regular therapeutic apheresis to manage disease progression and alleviate symptoms.

Regional Outlook

North America led the apheresis equipment and contributed over 40% share in 2023, supported by high healthcare expenditure, advanced infrastructure, strong adoption of medical technologies and a high prevalence of chronic and hematological diseases. The presence of key industry players and ongoing innovation reinforce the region's position. Asia Pacific is expected to grow substantially as rapid economic development and improved healthcare infrastructure in China, India and Japan enhance capacity, while government initiatives promote blood donation programs. Strong awareness and acceptance of apheresis among healthcare providers and patients ensure a steady and growing market in North America.

Key Players and Recent Developments

Major companies include Asahi Kasei Corporation, B. Braun SE, Cerus Corporation, Fresenius SE & Co. KGaA, Haemonetics Corporation, Haier Biomedical, Medica SPA, Miltenyi Biotec, NIKKISO Medical Europe GmbH, NxStage Medical, Inc., SB-KAWASUMI LABORATORIES, INC., TERUMO BCT, INC. and THERAKOS. In May 2025, Fresenius Medical Care completed the acquisition of Natera's Kidney Care business, including automated plasma exchange and filtration technologies, strengthening its apheresis portfolio. Collaborations, mergers and acquisitions are common strategies for expanding market reach.

More Trending Latest Reports By Polaris Market Research:

global-liquefied-petroleum-gas-lpg-market

methyl-methacrylate-market

fungicide-market

natural-dyes-market

global-wetsuit-market

mena-and-gcc-bus-market

1-3-butadiene-market

oat-milk-market

europe-human-growth-hormone-market